Evidence map›Paper›PMID 33393726›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2021

Genetic Association of a Gain-of-Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet's Disease.

Lourdes Ortiz Fernández, Patrick Coit, Vuslat Yilmaz, Sibel P Yentür, Fatma Alibaz-Oner, Kenan Aksu, Eren Erken, Nursen Düzgün, Gokhan Keser, Ayse Cefle and 27 more

Open access · bronzeAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The research progress of LACC1.Frontiers in immunology · 2025
    Review
  4. Article
  5. Article
  6. Behçet's syndrome: recent advances to aid diagnosis.Clinical and experimental medicine · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Genetics in Behcet's Disease: An Update Review.Frontiers in ophthalmology · 2022
    Review
  15. Behçet Disease: An Update for Dermatologists.American journal of clinical dermatology · 2021
    Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 10 countries.

Lourdes Ortiz FernándezUniversity of Pittsburgh, Pittsburgh, Pennsylvania.
Patrick CoitUniversity of Pittsburgh, Pittsburgh, Pennsylvania.
Vuslat YilmazIstanbul University, Istanbul, Turkey.
Sibel P YentürIstanbul University, Istanbul, Turkey.
Fatma Alibaz-OnerMarmara University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-6653-1758
Kenan AksuEge University School of Medicine, Izmir, Turkey.
Eren ErkenCukurova University School of Medicine, Adana, Turkey.
Nursen DüzgünAnkara University School of Medicine, Ankara, Turkey.
Gokhan KeserEge University School of Medicine, Izmir, Turkey.
Ayse CefleKocaeli University School of Medicine, Kocaeli, Turkey.
Ayten YaziciKocaeli University School of Medicine, Kocaeli, Turkey.
Andac ErgenOkmeydanı Research and Education Hospital, Istanbul, Turkey.
Erkan AlpsoyAkdeniz University School of Medicine, Antalya, Turkey.
Carlo SalvaraniAzienda USL-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Modena, Italy.
Bruno CasaliAzienda Ospedaliera Arcispedale Santa Maria Nuova-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Bünyamin KısacıkGaziantep University, Gaziantep, Turkey.
Ina KötterUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jörg HenesUniversity Hospital Tuebingen, Tuebingen, Germany.
Muhammet ÇınarUniversity of Health Sciences Turkey, Ankara, Turkey.
Arne SchaeferCharité University Medicine, Berlin, Germany.
Rahime M NohutcuHacettepe University Sihhiye, Ankara, Turkey.
Alexandra ZhernakovaUniversity of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
Cisca WijmengaUniversity of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
Fujio TakeuchiTokyo Seiei University, Tokyo, Japan.
Shinji HariharaUniversity of Tokyo Graduate School of Science, Tokyo, Japan.
Toshikatsu KaburakiJichi Medical University Saitama Medical Center, Saitama, Japan.
Meriam MessediResearch Laboratory of Molecular Bases of Human Diseases 12ES17 and University of Sfax, Sfax, Tunisia.
Yeong-Wook SongSeoul National University College of Medicine, Seoul, Republic of Korea.
Timuçin KaşifoğluEskisehir Osmangazi University School of Medicine, Eskisehir, Turkey.
F David CarmonaUniversidad de Granada and ibs.GRANADA Instituto de Investigación Biosanitaria, Granada, Spain.
Joel M GuthridgeOklahoma Medical Research Foundation, Oklahoma City.
Judith A JamesOklahoma Medical Research Foundation, Oklahoma City.ORCID 0000-0002-9574-7355
Javier MartinInstituto de Parasitología y Biomedicina 'López-Neyra', Granada, Spain.
María Francisca González EscribanoInstituto de Biomedicine de Sevilla, Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla, Seville, Spain.
Güher Saruhan-DireskeneliIstanbul University, Istanbul, Turkey.
Haner DireskeneliMarmara University School of Medicine, Istanbul, Turkey.
Amr H SawalhaUniversity of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-3884-962X
Istanbul University · TRUniversity of Pittsburgh · USAnkara University · TREge University · TRKocaeli Üniversitesi · TRMarmara University · TROklahoma Medical Research Foundation · USUniversity Medical Center Groningen · NLAkdeniz University · TRCharité - Universitätsmedizin Berlin · DECukurova University · TREskişehir Osmangazi University · TRGaziantep University · TRHacettepe University · TRHospital Universitario Virgen del Rocío · ESInstituto de Parasitología y Biomedicina "López - Neyra" · ESIstituti di Ricovero e Cura a Carattere Scientifico · ITJichi Medical University · JPOkmeydanı Eğitim ve Araştırma Hastanesi · TROspedale Santa Maria · IT

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Robert Hal Scofield · 2013 to 2026
$68.2M
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)P30AR073750 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES · 2018 to 2026
$8.5M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
Pre-Clinical Studies to Identify SLE Therapeutic TargetsU19AI082714 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2009 to 2018
$6.2M
Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail SuccessUM1AI144292 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES · 2019 to 2026
$3.3M
Characterizing the Takayasu Arteritis Genetic Risk in RPS9/LILRB3R01AR070148 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SAWALHA, AMR H · 2017 to 2022
$1.7M
NIAID NIH HHS U19 AI082714NIAID NIH HHS UM1 AI144292NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P30 AR073750NIAMS NIH HHS R01 AR070148NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

objectiveBehçet's disease is a complex systemic inflammatory vasculitis of incompletely understood etiology. This study was undertaken to investigate genetic associations with Behçet's disease in a diverse multiethnic population.

methodsA total of 9,444 patients and controls from 7 different populations were included in this study. Genotyping was performed using an Infinium ImmunoArray-24 v.1.0 or v.2.0 BeadChip. Analysis of expression data from stimulated monocytes, and epigenetic and chromatin interaction analyses were performed.

resultsWe identified 2 novel genetic susceptibility loci for Behçet's disease, including a risk locus in IFNGR1 (rs4896243) (odds ratio [OR] 1.25; P = 2.42 × 10

conclusionWe performed the largest genetic association study in Behçet's disease to date. Our findings reveal novel putative functional variants associated with the disease and replicate and extend the genetic associations in other loci across multiple ancestries.

Indexed as

Behcet SyndromeCase-Control StudiesChromosomes, Human, Pair 10DNA, IntergenicEpigenesis, GeneticFemaleGain of Function MutationGene Expression RegulationGenetic Predisposition to DiseaseHumansIntercellular Signaling Peptides and ProteinsInterferon gamma ReceptorLipopolysaccharidesMaleMonocytesPolymorphism, Single NucleotideDKK1 protein, humanDNA, IntergenicIntercellular Signaling Peptides and ProteinsInterferon gamma ReceptorLipopolysaccharidesReceptors, InterferonRNA, Long NoncodingRNA, Messenger

Identifiers

PMID33393726
PMCPMC8238846
OpenAlexW3118349944

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.